94 related articles for article (PubMed ID: 3024136)
21. Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients.
Hataji O; Taguchi O; Gabazza EC; Yuda H; D'Alessandro-Gabazza CN; Fujimoto H; Nishii Y; Hayashi T; Suzuki K; Adachi Y
Am J Hematol; 2004 Jul; 76(3):214-9. PubMed ID: 15224354
[TBL] [Abstract][Full Text] [Related]
22. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
23. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
24. Fibrinolysis in human bronchogenic carcinoma.
Peterson HI; Larsson S; Zettergren L
Bibl Anat; 1975; 13():315-6. PubMed ID: 182114
[No Abstract] [Full Text] [Related]
25. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
[TBL] [Abstract][Full Text] [Related]
27. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
Wu Y; Wu Y; Wang L; Qu L
Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
[TBL] [Abstract][Full Text] [Related]
28. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
[TBL] [Abstract][Full Text] [Related]
30. Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
Brugarolas A; Elias EG; Takita H; Mink IB; Mittelman A; Ambrus JL
J Med; 1973; 4(2):96-105. PubMed ID: 4127138
[No Abstract] [Full Text] [Related]
31. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
32. Alteration of A549 carcinoma cell protein synthesis profile induced by lung cancer patient serum.
Machado Paschoal ME; Da Glória Da Costa Carvalho M
Int J Mol Med; 2001 Aug; 8(2):211-5. PubMed ID: 11445877
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the correlation of blood selenium and lung cancer. II. An analysis of serum selenium levels and influencing factors in patients with lung cancer].
Hu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):346-9. PubMed ID: 8156579
[TBL] [Abstract][Full Text] [Related]
34. Tissue polypeptide antigen in bronchogenic carcinoma.
Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
[TBL] [Abstract][Full Text] [Related]
35. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
[TBL] [Abstract][Full Text] [Related]
36. [Parathyrin content of lung cancer patients undergoing surgical and chemotherapeutic treatment].
Afrikian MN; Tkacheva GA; Abramov VF
Med Radiol (Mosk); 1983 Apr; 28(4):31-3. PubMed ID: 6300611
[TBL] [Abstract][Full Text] [Related]
37. [Tumor markers in the diagnosis of lung cancer].
Tokarskaia ZB; Surina AG; Mamakova OV
Ter Arkh; 1983; 55(10):117-21. PubMed ID: 6196848
[No Abstract] [Full Text] [Related]
38. Galactorrhoea with gynecomastia in a male with lung cancer.
Behera D; Kalra S; Nalini K; Malik SK; Jindal SK; Dash RJ
Indian J Chest Dis Allied Sci; 1987; 29(2):112-4. PubMed ID: 3121500
[No Abstract] [Full Text] [Related]
39. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
[TBL] [Abstract][Full Text] [Related]
40. [Levels of serum soluble tumor necrosis factor receptor in patients with lung cancer].
Yan GM; Lui JY; Yang HZ
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):515, 517. PubMed ID: 12212141
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
